The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

(2012) Zhen Liu et al.   BMC CANCER

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer

(2012) K Kaira et al.   BRITISH JOURNAL OF CANCER

High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas

(2012) Nobuyuki Yanagisawa et al.   JOURNAL OF CLINICAL PATHOLOGY

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

(2010) Luxia Tu et al.   Molecular Cancer

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer

(2009) Hisao Imai et al.   HISTOPATHOLOGY

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

(2008) K Kaira et al.   BRITISH JOURNAL OF CANCER

L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer

(2008) Takeshi Sakata et al.   PATHOLOGY INTERNATIONAL